Improving HIV testing, linkage, and retention in care among South African men through U = U messaging: A study protocol for two sequential hybrid type 1 effectiveness-implementation randomized controlled trials

被引:0
作者
Medina-Marino, Andrew [1 ,2 ,3 ]
Sibanda, Nkosiyapha [1 ,2 ]
Putt, Mary [4 ]
Joseph Davey, Dvora [1 ,5 ,6 ,7 ]
Smith, Phillip [1 ,2 ]
Thirumurthy, Harsha [8 ,9 ]
Bekker, Linda-Gail [1 ,2 ]
Buttenheim, Alison [9 ,10 ]
机构
[1] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa
[2] Desmond Tutu Hlth Fdn, Cape Town, South Africa
[3] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA
[5] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA USA
[7] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa
[8] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA USA
[9] Univ Penn, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA
[10] Univ Penn, Sch Nursing, Dept Family & Community Hlth, Philadelphia, PA 19104 USA
来源
PLOS ONE | 2024年 / 19卷 / 11期
基金
美国国家卫生研究院;
关键词
HUMAN-CENTERED DESIGN; ANTIRETROVIRAL THERAPY; PREVENTION; HEALTH; INTERVENTION; INSIGHTS; BELIEF;
D O I
10.1371/journal.pone.0309905
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings.Methods Building on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men's uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa.Discussion These trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.
引用
收藏
页数:24
相关论文
共 8 条
  • [1] An Integrated Care Pathway for depression in adolescents: protocol for a Type 1 Hybrid Effectiveness-implementation, Non-randomized, Cluster Controlled Trial
    Courtney, Darren B.
    Barwick, Melanie
    Amani, Bahar
    Greenblatt, Andrea T.
    Aitken, Madison
    Krause, Karolin R.
    Andrade, Brendan F.
    Bennett, Kathryn
    Cleverley, Kristin
    Uliaszek, Amanda A.
    de Oliveira, Claire
    Hawke, Lisa D.
    Henderson, Jo
    Wang, Wei
    Watson, Priya
    Gajaria, Amy
    Newton, Amanda S.
    Ameis, Stephanie
    Relihan, Jacqueline
    Prebeg, Matthew
    Chen, Sheng
    Szatmari, Peter
    BMC PSYCHIATRY, 2024, 24 (01)
  • [2] Study protocol for testing the efficacy of the Helping Educational Leaders Mobilize Evidence (HELM) implementation strategy in elementary schools: a hybrid type 3 effectiveness-implementation randomized controlled trial
    Locke, Jill
    Williams, Nathaniel J.
    Sridhar, Aksheya
    Ehrhart, Mark G.
    Dopp, Alex
    Thirion, Marissa
    Espeland, Christine
    Riddle, Brandon
    Schmitz, Kelcey
    Hatch, Kurt
    Buehler, Lindsey
    Lyon, Aaron R.
    IMPLEMENTATION SCIENCE, 2025, 20 (01):
  • [3] Mothers and Babies Virtual Group (MBVG) for perinatal Latina women: study protocol for a hybrid type-1 effectiveness-implementation randomized controlled trial
    Platt, Rheanna
    Polk, Sarah
    Barrera, Alinne Z.
    Lara-Cinisomo, Sandraluz
    Hirschhorn, Lisa R.
    Graham, Andrea K.
    Musci, Rashelle J.
    Hamil, Jaime
    Echavarria, Diane
    Cooper, Lindsay
    Tandon, S. Darius
    TRIALS, 2024, 25 (01)
  • [4] Digital interventions to promote physical activity among inactive adults: A study protocol for a hybrid type I effectiveness-implementation randomized controlled trial
    Zanaboni, Paolo
    Manskow, Unn Sollid
    Sagelv, Edvard Hamnvik
    Morseth, Bente
    Edvardsen, Alf Egil
    Aamot, Inger-Lise
    Nes, Bjarne Martens
    Hastings, Bryce
    Gagnon, Marie-Pierre
    Antypas, Konstantinos
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [5] Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania
    Kadota, Jillian L.
    Packel, Laura J.
    Mlowe, Matilda
    Ulenga, Nzovu
    Mwenda, Natalino
    Njau, Prosper F.
    Dow, William H.
    Wang, Jingshen
    Sabasaba, Amon
    Mccoy, Sandra I.
    TRIALS, 2024, 25 (01)
  • [6] Project Khanya: results from a pilot randomized type 1 hybrid effectiveness-implementation trial of a peer-delivered behavioural intervention for ART adherence and substance use in HIV care in South Africa
    Magidson, Jessica F.
    Joska, John A.
    Belus, Jennifer M.
    Andersen, Lena S.
    Regenauer, Kristen S.
    Rose, Alexandra L.
    Myers, Bronwyn
    Majokweni, Sybil
    O'Cleirigh, Conall
    Safren, Steven A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [7] ENABLE-SG (Educate, Nurture, Advise, Before Life Ends for Singapore) as a proactive palliative care model: protocol for a hybrid type 1 effectiveness-implementation randomized wait-list controlled trial
    Ke, Yu
    Cheung, Yin Bun
    Bakitas, Marie
    Odom, J. Nicholas
    Lum, Elaine
    Tan, Daniel Shao Weng
    Tan, Tira J.
    Finkelstein, Eric
    Oh, Hong Choon
    Zhou, Siqin
    Yang, Grace Meijuan
    BMC PALLIATIVE CARE, 2024, 23 (01) : 29
  • [8] Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts
    Cox, Samyra R.
    Kadam, Abhay
    Atre, Sachin
    Gupte, Akshay N.
    Sohn, Hojoon
    Gupte, Nikhil
    Sawant, Trupti
    Mhadeshwar, Vishal
    Thompson, Ryan
    Kendall, Emily
    Hoffmann, Christopher
    Suryavanshi, Nishi
    Kerrigan, Deanna
    Tripathy, Srikanth
    Kakrani, Arjunlal
    Barthwal, Madhusudan S.
    Mave, Vidya
    Golub, Jonathan E.
    TRIALS, 2022, 23 (01)